About Auris Medical
Auris Medical is a company based in Basel (Switzerland) founded in 2003.. Auris Medical has raised $60.68 million across 4 funding rounds from investors including Hercules Capital, Idinvest Partners and Sofinnova Partners. Auris Medical offers products and services including AM-401, AM-411, Bentrio Nasal Spray, and Inner Ear Therapeutics. Auris Medical operates in a competitive market with competitors including Lyra Therapeutics, Decibel Therapeutics, Perceive Bio, Akouos and Spiral Therapeutics, among others.
- Headquarter Basel, Switzerland
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Altamira Therapeutics Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$60.68 M (USD)
in 4 rounds
-
Latest Funding Round
$5.5 M (USD), Post-IPO
Feb 09, 2018
-
Investors
Hercules Capital
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Auris Medical
Auris Medical offers a comprehensive portfolio of products and services, including AM-401, AM-411, Bentrio Nasal Spray, and Inner Ear Therapeutics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targets KRAS-driven cancer through RNA delivery technologies
Addresses rheumatoid arthritis via preclinical RNA therapeutics
Focuses on allergy treatments being divested
Develops solutions for inner ear disorders for potential licensing
Unlock access to complete
Leadership Team
6 people
Finance and Accounting
1 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of Auris Medical
Auris Medical has successfully raised a total of $60.68M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $5.5 million completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $5.5M
-
First Round
First Round
(15 Feb 2008)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2018 | Amount | Post-IPO - Auris Medical | Valuation |
investors |
|
| Jul, 2016 | Amount | Debt – Venture - Auris Medical | Valuation |
investors |
|
| Apr, 2013 | Amount | Series C - Auris Medical | Valuation | Sofinnova Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Auris Medical
Auris Medical has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Hercules Capital, Idinvest Partners and Sofinnova Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt financing is provided to companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Founded Year | Domain | Location | |
|
Equity investments are provided to low and middle market companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Auris Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Auris Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Auris Medical Comparisons
Competitors of Auris Medical
Auris Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lyra Therapeutics, Decibel Therapeutics, Perceive Bio, Akouos and Spiral Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecule therapeutics for ENT diseases are developed.
|
|
| domain | founded_year | HQ Location |
Medicines are developed to protect, repair, and restore hearing capacity.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics to treat diabetes and eye diseases
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies to restore and preserve hearing capabilities in genetically defined populations
|
|
| domain | founded_year | HQ Location |
Therapeutics for balance disorders and hearing loss are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Auris Medical
Frequently Asked Questions about Auris Medical
When was Auris Medical founded?
Auris Medical was founded in 2003 and raised its 1st funding round 5 years after it was founded.
Where is Auris Medical located?
Auris Medical is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Is Auris Medical a funded company?
Auris Medical is a funded company, having raised a total of $60.68M across 4 funding rounds to date. The company's 1st funding round was a Series C of $50.6M, raised on Feb 15, 2008.
What does Auris Medical do?
Auris Medical is dedicated to developing novel pharmaceutical therapies for inner ear diseases tinnitus, hearing loss and menieres disease. Pipeline includes 2 late stage candidates AM-101 for tinnitus and AM-111 for sudden deafness. Other preclinical stage candidates include AM-102 for tinnitus and AM-123 for rhinology study. Company has also developed Intratympanic injection to deliver low drug doses to inner ear and minimize systemic side effects.
Who are the top competitors of Auris Medical?
Auris Medical's top competitors include Decibel Therapeutics, Lyra Therapeutics and Akouos.
What products or services does Auris Medical offer?
Auris Medical offers AM-401, AM-411, Bentrio Nasal Spray, and Inner Ear Therapeutics.
Who are Auris Medical's investors?
Auris Medical has 3 investors. Key investors include Hercules Capital, Idinvest Partners, and Sofinnova Partners.